Glycopyrrolate and indacaterol inhalation and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Glycopyrrolate and indacaterol inhalation and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glycopyrrolate / indacaterol
Brand name: Utibron Neohaler
Synonyms: Glycopyrrolate and indacaterol (inhalation), Indacaterol and Glycopyrrolate
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glycopyrrolate and indacaterol inhalation-Moxifloxacin
- Glycopyrrolate and indacaterol inhalation-Moxifloxacin (Systemic)
- Glycopyrrolate and indacaterol inhalation-Moxifloxacin Hydrochloride
- Glycopyrrolate and indacaterol inhalation-Moxifloxacin Injection
- Glycopyrrolate and indacaterol inhalation-Moxifloxacin Intravenous
- Glycopyrrolate and indacaterol inhalation-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Glycopyrrolate Capsules for Inhalation
- Moxetumomab pasudotox-tdfk Intravenous-Glycopyrrolate inhalation
- Moxetumomab pasudotox-tdfk Intravenous-Glycopyrrolate Inhalation Solution
- Moxetumomab pasudotox-tdfk Intravenous-Glycopyrrolate Injection
- Moxetumomab pasudotox-tdfk Intravenous-Glycopyrrolate Intramuscular, Intravenous
- Moxetumomab pasudotox-tdfk Intravenous-Glycopyrrolate Oral Solution